NCT07491952From ClinicalTrials.govRecruiting

Continuous Dual Aspiration Technique With Zoom System for Stroke

Clinical Evaluation of Continuous Dual Aspiration Technique With Zoom System for Stroke (ADAPT 2.0)

Ischemic Stroke
Acute Stroke

At a glance

Phase: Phase not stated
Study type: Observational
Sponsor: Imperative Care, Inc.
Enrolment target: 750
Started: 24 March 2026
Main results due: 31 March 2030
Study sites: 22
Registry updated: 28 September 2026

Can you take part?

Aged 18 years and over.
Open to any sex.
You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria

Inclusion Criteria:

1. Subject is ≥ 18 years of age
2. Subject or legally authorized representative has provided written informed consent prior to any study-specific procedures and no later than 72 hours after the index procedure
3. Pre-stroke mRS 0-2
4. Subject is undergoing or has undergone an aspiration thrombectomy using the Zoom System with Continuous Dual Aspiration Technique (CDAT) as the first line device within its intended use

Exclusion Criteria:

1. Subjects with a life expectancy of less than 6 months
2. Female subject who is known to be pregnant at time of admission
3. Any intracranial hemorrhage in the qualifying head CT or MRI
4. Presence of tandem internal carotid artery occlusion, multiple occlusion locations (e.g., cavernous ICA and M1, separate M2 occlusions, etc.), or occlusions in multiple territories (e.g., MCA and ACA, bilateral, etc.).
5. In the opinion of the Investigator, the patient is not a suitable candidate for intervention with the Zoom System
6. Subject is currently enrolled in or planned to be enrolled in any concurrent interventional study that may impact the safety or performance data collected in this study

What this study is about

In the sponsor’s own words, from the registry.

This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).

Study sites(22)

Huntsville Hospital
Huntsville, Alabama, United States
Recruiting
John Muir Health
Walnut Creek, California, United States
Recruiting
University of South Florida
Tampa, Florida, United States
Recruiting
Wellstar Kennestone Hospital
Marietta, Georgia, United States
Recruiting
Ochsner Clinic Foundation (Lafayette)
Lafayette, Louisiana, United States
Recruiting
Ochsner Clinic Foundation
New Orleans, Louisiana, United States
Recruiting
University of Maryland
Baltimore, Maryland, United States
Recruiting
Allina Health
Minneapolis, Minnesota, United States
Recruiting
Albany Medical College
Albany, New York, United States
Recruiting
University at Buffalo Neurosurgery
Buffalo, New York, United States
Recruiting
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Recruiting
Montefiore Medical Center
The Bronx, New York, United States
Recruiting
University of Oklahoma, Health Science Center
Oklahoma City, Oklahoma, United States
Recruiting
Prisma Health - Upstate
Greenville, South Carolina, United States
Recruiting
Fort Sanders Regional Medical Center
Knoxville, Tennessee, United States
Recruiting
Semmes Murphey Foundation
Memphis, Tennessee, United States
Recruiting
HCA Houston Healthcare Kingwood
Kingwood, Texas, United States
Recruiting
Methodist Healthcare System of San Antonio
San Antonio, Texas, United States
Recruiting
University of Texas Science Health Center at San Antonio
San Antonio, Texas, United States
Recruiting
University of Utah
Salt Lake City, Utah, United States
Recruiting
Inova Fairfax Medical Campus
Falls Church, Virginia, United States
Recruiting
Providence Sacred Heart Medical Center and Children's Hospital
Spokane, Washington, United States
Recruiting

Showing 22 of 22 sites. 22 of the 22 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07491952. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me